Anti-Trypanosoma cruzi inconclusive results in blood donor screening

Anti-Trypanosoma cruzi inconclusive results in blood donor screening

Bibliographic Details
Main Author:	Márcia Mitiko Otani
Format:	Article
Language:	English
Published:	Elsevier 2012-01-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000400006

Similar Items

Performance of six diagnostic tests to screen for Chagas disease in blood banks and prevalence of Trypanosoma cruzi infection among donors with inconclusive serology screening based on the analysis of epidemiological variables
by: Gilberto de Araujo Pereira, et al.
Published: (2012-01-01)

Risk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood Donors.
by: Ed Slot, et al.
Published: (2016-01-01)

Anti-Trypanosoma cruzi antibody detection in blood donors in the Southern Brazil
by: A.B. Araújo, et al.

Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases
by: Márcia M Ferreira-Silva, et al.
Published: (2010-09-01)

Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors.
by: Antonio L Ribeiro, et al.
Published: (2013-01-01)

Infecção por Trypanosoma cruzi em candidatos a doador de sangue Trypanosoma cruzi infection in blood donors
by: Ana M. Bonametti, et al.
Published: (1998-12-01)

Trypanosoma cruzi prevalence and clinical forms in blood donor candidates in Brazil
by: H J Silveira, et al.

Trypanosoma cruzi prevalence and clinical forms in blood donor candidates in Brazil
by: H J Silveira, et al.
Published: (2003-12-01)

Trypanosoma cruzi prevalence and clinical forms in blood donor candidates in Brazil
by: Silveira H J, et al.
Published: (2003-01-01)

Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Bahia, Brazil
by: Diego Lopes Paim Miranda, et al.

Risk factors for Trypanosoma cruzi infection among blood donors in Central Brazil
by: Celina M. T. Martelli, et al.
Published: (1992-09-01)

Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico.
by: Gilberto Sánchez-González, et al.
Published: (2016-03-01)

High throughput screening for anti-Trypanosoma cruzi drug discovery.
by: Julio Alonso-Padilla, et al.
Published: (2014-12-01)

Coping strategies and emotional distress in women with inconclusive results in screening mammography
by: María del Carmen Cardenal Ciudad, et al.
Published: (2014-12-01)

High prevalence anti-Trypanosoma cruzi antibodies, among blood donors in the State of Puebla, a non-endemic area of Mexico
by: MC Sánchez-Guillén, et al.
Published: (2002-10-01)

Blood transfusion and iatrogenic risks in Mexico city: anti-Trypanosoma cruzi seroprevalence in 43,048 blood donors, evaluation of parasitemia, and electrocardiogram findings in seropositive
by: Nidia Hernández-Becerril, et al.
Published: (2005-04-01)

The application of latent class analysis for diagnostic test validation of chronic Trypanosoma cruzi infection in blood donors
by: Dante M. Langhi Junior, et al.

The application of latent class analysis for diagnostic test validation of chronic Trypanosoma cruzi infection in blood donors
by: Langhi Junior Dante M., et al.
Published: (2002-01-01)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
by: Anne Munck
Published: (2020-03-01)

Inconclusive HIV-1/2 results: how far should blood centers go?
by: Bassetti-Soares Eric, et al.
Published: (2001-01-01)

Inconclusive HIV-1/2 results: how far should blood centers go?
by: Eric Bassetti-Soares, et al.

Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity
by: Nieves Martinez-Peinado, et al.
Published: (2020-06-01)

Repurposing of terconazole as an anti Trypanosoma cruzi agent
by: Chantal Reigada, et al.
Published: (2019-06-01)

Synthesis and Anti-Trypanosoma cruzi Activity of Diaryldiazepines
by: Júlio César L. Menezes, et al.
Published: (2014-12-01)

Trypanosoma cruzi prevalence and clinical forms in blood donor candidates in Brazil Prevalência e formas clínicas de Trypanosoma cruzi em candidatos a doadores de sangue no Brasil
by: H J Silveira, et al.
Published: (2003-12-01)

Trypanosoma cruzi
by: María Teresa Palá, et al.
Published: (2000-03-01)

Trypanosoma cruzi seroprevalence among solid organ donors in Ceará State, Brazil
by: Alanna Carla da Costa, et al.

Distribución heterogénea de la prevalencia de anticuerpos contra Trypanosoma cruzi en donadores de sangre en Puebla, México Heterogeneous distribution of the prevalence of anti-Trypanosoma cruzi antibodies among blood donors in the State of Puebla, Mexico
by: Víctor M Monteón, et al.
Published: (2005-04-01)

Activity in vivo of anti-Trypanosoma cruzi compounds selected from a high throughput screening.
by: Grasiella Andriani, et al.
Published: (2011-08-01)

Inconclusive Syphilis Results: A Retrospective Review of Public Health Results
by: Patrick O’Byrne, et al.
Published: (2020-01-01)

Occurrence of Leishmania chagasi, Trypanosoma cruzi, Babesia canis vogeli, Anaplasma platys, and Ehrlichia canis in canine blood donors
by: Felipe Augusto Constantino Seabra da Cruz, et al.
Published: (2017-03-01)

Disagreement between PCR and serological diagnosis of Trypanosoma cruzi infection in blood donors from a Colombian endemic region
by: Liliana Torcoroma García Sánchez, et al.
Published: (2021-05-01)

Microalgae extracts: Potential anti-Trypanosoma cruzi agents?
by: Rhonda Veas, et al.
Published: (2020-07-01)

Norfloxacin and N-Donor Mixed-Ligand Copper(II) Complexes: Synthesis, Albumin Interaction, and Anti-Trypanosoma cruzi Activity
by: Darliane A. Martins, et al.
Published: (2016-01-01)

Trypanosoma cruzi ou Schizotrypanum cruzi?
by: Emmanuel Dias
Published: (1934-11-01)

Biology of Trypanosoma cruzi: An update Biología del Trypanosoma cruzi: Actualización
by: André Vianna Martins, et al.
Published: (2012-03-01)

Targeted screening strategies to detect Trypanosoma cruzi infection in children.
by: Michael Z Levy, et al.
Published: (2007-12-01)

Correction: Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
by: The Staff
Published: (2014-10-01)

Benznidazole therapy for Chagas disease in asymptomatic Trypanosoma cruzi -seropositive former blood donors: evaluation of the efficacy of different treatment regimens
by: André Pires Antunes, et al.

Characterization of Trypanosoma cruzi
by: Silvane Maria Fonseca Murta, et al.
Published: (1999-09-01)

Cannot write session to /tmp/vufind_sessions/sess_lrlfm0b9i2vokrqeol446goo68